100% Same
Salt CompositionEffectivenessStrength
with Substitute Medicine
Heparin 25000IU


WHO GMP
Certified

15 Days Easy
Returns

Long Expiry
(>8 Months)

WHO GMP
Certified

15 Days Easy
Returns

Long Expiry
(>8 Months)
Delivery by
In Prevention of Blood clots : Formation of blood clots blocks one or more veins, usually in your legs. 6i Hep 25000iu/5ml Injection is used to prevent formation of blood clots near the surface of your skin. It dissolves the clots and also relieves pain and inflammation by increasing the blood flow. This improves the overall healing process.6i
Side effects of 6i Hep Injection The majority of side effects typically do not necessitate medical intervention. and disappear as your body adjusts to the medicine. Doctor consultation is advised if they persist or if you�re worried about them Common side effects of 6i Hep Bleeding Erythema (skin redness)
How to use 6i Hep Injection
How 6i Hep Injection works6i
Unsafe: Avoid consuming alcohol with 6i Hep 25000iu/5ml Injection as it is deemed unsafe.
6i Hep 25000iu/5ml Injection may be unsafe to use during pregnancy. Although there are limited studies in humans, animal studies have shown harmful effects on the developing baby. Your doctor will weigh the benefits and any potential risks before prescribing it to you. Doctor consultation is advised.
6i Hep 25000iu/5ml Injection is safe to use during breastfeeding. Human studies suggest that the drug does not pass into the breastmilk in a significant amount and is not harmful to the baby.6i
6i Hep 25000iu/5ml Injection does not usually affect your ability to drive.
6i Hep 25000iu/5ml Injection is safe to use in patients with kidney disease. No dose adjustment of 6i
There is limited information available on the use of 6i Hep 25000iu/5ml Injection in patients with liver disease. Doctor consultation is advised.
If a dose of 6i Hep 25000iu/5ml Injection is missed, it's advisable to consult your doctor.
49 KHASRA NO 53/2/1 HASANPUR VILLAGE I.P.EXTN DELHI East Delhi DL 110092 IN
Weitz JI. Blood Coagulation and Anticoagulant, Fibrinolytic, and Antiplatelet Drugs. In: Brunton LL, Chabner BA, Knollmann BC, editors. Goodman & Gilmans: The Pharmacological Basis of Therapeutics. 12th ed. New York, New York: McGraw-Hill Medical; 2011. pp. 853-59
Zehnder JL. Drugs Used in Disorders of Coagulation. In: Katzung BG, Masters SB, Trevor AJ, editors. Basic and Clinical Pharmacology. 11th ed. New Delhi, India: Tata McGraw Hill Education Private Limited; 2009. pp. 591-93
Fox KA, White HD, Gersh BJ, et al. Antithrombotic Agents: Platelete Inhibitors, Acute Anticoagulants, Fibrinolytics, and Chronic Anticoagulants. In: Opie LH, Gersh BJ, editors. Drugs for the Heart. 8th ed. Philadelphia, Pennsylvania: Elsevier Saunders; 2013. pp. 367-73
Briggs GG, Freeman RK, editors. A Reference Guide to Fetal and Neonatal Risk: Drugs in Pregnancy and Lactation. 10th ed. Philadelphia, PA: Wolters Kluwer Health; 2015. pp. 652-53
Heparin sodium. Hurley, Berkshire: Leo Laboratories Limited; 1975 (18 Mar. 2019)
Drugs.com. Heparin Pregnancy and Breastfeeding Warnings (18 Mar. 2019)
Chaves RG, Lamounier JA. Breastfeeding and maternal medications. J Pediatr (Rio J). 2004;80(5 Suppl):S189-S198 (18 Mar. 2019)
Central Drugs Standard Control Organisation (CDSCO). Heparin (18 Mar. 2019)
PlatinumRx is dedicated to delivering dependable and trustworthy information to empower our customers. However, the information presented here is solely for general informational purposes and should not be utilized for diagnosing, preventing, or treating health issues. It is not intended to establish a doctor-patient relationship or serve as a substitute for professional medical advice.